Package: 3 Vials 2ml [100 mg/ml.] in plastic tray.
Substance: nandrolone phenilpropinoate
Produced by: B.M. Pharmaceuticals (India)
Nandrolone is chemically related to the male hormone. Compared to testosterone, it has an enhanced anabolic and a reduced androgenic activity. This has been demonstrated in animal bioassays and explained by receptor binding studies. The low androgenicity of nandrolone is confirmed in clinical use. In the human, nandrolone has been shown to positively influence calcium metabolism and to increase bone mass in osteoporosis. In women with disseminated mammary carcinoma, Nandrolone has been reported to produce objective regressions for many months. Furthermore, Nandrolone has a nitrogen-saving action. This effect on protein metabolism has been established by metabolic studies and is utilised therapeutically in conditions where a protein deficiency exists such as during chronic debilitating diseases and after major surgery and severe trauma. In these conditions, Nandrolone Phenylpropionate serves as a supportive adjunct to specific therapies and dietary measures as well as parenteral nutrition, due to it's faster acting nature Nandrolone phenylpropionate is preffered in situations where a faster clinical response is required over it's chemical variant Nandrolone decaonate.
Nandrolone Phenylpropionate (Dubol - 100)
Each ml. contains: Nandrolone Phenylpropionate B.P. 100 mg.; Benzyl Alcohol I.P. 0.05 ml.; isopyl Alcohol I.P. 0.2 ml.; Arachis Oil I.P. q.s.
As directed by the Physician.Multiple dose vial. Protect from light. For I.M. use only. Not to be refrigerated.
Dubol is a long acting anabolic preparation containing Nandrolone Phenypropionate.
Dubol promotes protein anabolism and also provides beneficial effects in senile osteoporosis. It improves general conditions in debilitated and convalescing patients and shortens recovery time. It improves appetite and provides a general sense of being in convalescent patients. Metabolic studies have shown positive effects on protein metabolism, nitrogen saving effects and anti catabolic action. A decrease in urinary calcium has been reported in cases of increased calceamia.
Nandrolone Phenypropionate is long acting oily preparation which releases the drug slowly after intramuscular administration. This leads to prolonged duration of action and infrequent dosage schedule.
Tissue building and repair before and after surgery, after severe injures and burns, after severe infectious diseases, osteoporosis, acute and chronic renal insufficiency, mammary carcinoma, aplastic anaemia, refractory anaemia and hemolytic anaemia, general debility, malnutrition, poor weight gain and in geriatric conditions.
Contradictions: Pregnancy, prostatic carcinoma or mammary carcinoma in males.
For an optimal therapeutic effect, adequate amount of proteins, vitamins and minerals should be administered in a calorie rich diet. Recommended doses should not be exceeded. If signs of virilistation develop, discontinuation of the treatment should be considered.
Patients with following conditions should be monitored. Latent or overt cardiac failure, renal dysfunction, hypertension, epilepsy or migraine, diabetes or latent diabetes, mammary carcinoma and metastasis.
Dosage: As directed by Physician.
Dubol has a relatively week androgenic effect. Virilisation of foetus may occur if used during pregnancy. Prolonged treatment with high doses in prepuberty in children may cause closure of epiphyses. Unlike 17-alpha Alkyl substituted steroids, is not associated increases risk of liver damage.